A viral video claimed GLP-1 drugs cause cancer and blindness. Researchers are still studying long-term safety, including the thyroid tumor warning.
Recap by typeshit. Full story at Riverside Homestead on MSN.
NSW peptide hospitalisations went from five in July 2025 to over 200 in September 2026, and needle programs say syringe machines are emptying within hours.
Bikman says midface volume drops about 7% for every 10 kg lost, and that bariatric surgery patients see the same change.
A woman with bipolar disorder developed tremor and slurred speech three weeks into Zepbound. An outside expert advises checking lithium levels early, not avoiding the drugs.
8:51
Regan Archibald takes on a common question from people using retatrutide: whether the tiredness some report wears off.
MD Aman Mehta gave the timeline as Brazil revenue rose 38%. In India, Torrent holds a 32% share of generic semaglutide after a two-month supply gap.
Mariem Dekhili's weekly overview covers GLP-1 eye warnings alongside the Pope's France visit and Russia in the Sahel.
Loading…